Literature DB >> 28433385

Perioperative risks of narcolepsy in patients undergoing general anesthesia: A case-control study.

Alexandre N Cavalcante1, Ryan E Hofer2, Maja Tippmann-Peikert3, Juraj Sprung2, Toby N Weingarten4.   

Abstract

STUDY
OBJECTIVE: To compare the perioperative outcomes between patients with narcolepsy and matched controls undergoing anesthetic management.
DESIGN: Retrospective 2:1 matched study design.
SETTING: Large tertiary medical center. PATIENTS: Narcoleptic patients who underwent general anesthesia from January 1, 2011, through September 30, 2015, were matched with controls by age, sex, and type and year of surgery. MEASUREMENTS: Medical records were reviewed for episodes of respiratory depression during phase I recovery and for other meaningful perioperative outcomes. MAIN
RESULTS: The perioperative courses of 76 narcoleptic patients and their controls were examined. Compared to controls, narcoleptic patients were more often prescribed central nervous system stimulants (73.7% vs 4.0%, P<0.001) and antidepressants (46.1% vs 27.6%, P=0.007) and more often had obstructive sleep apnea (40.8% vs 19.1%, P<0.001). The intraoperative course was similar. The number of episodes of respiratory depression was not different between patients and controls (5 [6.6%] vs 12 [7.9%], respectively; P=0.80). Narcoleptic patients had a higher frequency of emergency response team activations (5 of 76 [6.6%]; 95% CI, 2.2%-14.7%) compared to controls (2 of 152 [1.3%]; 95% CI, 0.2%-4.7%) (P=0.04). Hemodynamic instability was the indication for all emergency response team activations except 1, which was for a narcoleptic patient who had excessive postoperative sedation and respiratory depression.
CONCLUSIONS: Narcoleptic patients had similar intraoperative courses as the matched controls, including phase I anesthetic recovery. However, they had a higher rate of emergency response team activations than the controls, which suggests that patients with narcolepsy may be at increased perioperative risk.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emergency response teams; General anesthesia; Hemodynamic instability; Narcolepsy; Respiratory depression

Mesh:

Substances:

Year:  2017        PMID: 28433385     DOI: 10.1016/j.jclinane.2017.04.008

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

1.  Perioperative outcomes of patients with restless legs syndrome: a single-center retrospective review.

Authors:  Bhargavi Gali; Michael H Silber; Andrew C Hanson; Erica Portner; Peter Gay
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

Review 2.  The link between narcolepsy and autonomic cardiovascular dysfunction: a translational perspective.

Authors:  Chiara Berteotti; Alessandro Silvani
Journal:  Clin Auton Res       Date:  2017-10-10       Impact factor: 4.435

3.  Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia.

Authors:  Michael J Venincasa; Owen Randlett; Sureni H Sumathipala; Richard Bindernagel; Matthew J Stark; Qing Yan; Steven A Sloan; Elena Buglo; Qing Cheng Meng; Florian Engert; Stephan Züchner; Max B Kelz; Sheyum Syed; Julia E Dallman
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

4.  Anesthetic management of a patient with narcolepsy by combination of total intravenous and regional anesthesia: a case report.

Authors:  Daiki Takekawa; Tetsuya Kushikata; Masato Kitayama; Kazuyoshi Hirota
Journal:  JA Clin Rep       Date:  2017-07-14

5.  Central Disorders of Hypersomnolence, Restless Legs Syndrome, and Surgery With General Anesthesia: Patient Perceptions.

Authors:  Vincent LaBarbera; Paul S García; Donald L Bliwise; Lynn M Trotti
Journal:  Front Hum Neurosci       Date:  2018-03-20       Impact factor: 3.169

Review 6.  Sleep Disturbances After General Anesthesia: Current Perspectives.

Authors:  Man Luo; Bijia Song; Junchao Zhu
Journal:  Front Neurol       Date:  2020-07-08       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.